Full Press Release Details
ALTERITY THERAPEUTICS LIMITED
Date of this announcement
Monday April 15, 2024
The +securities to be quoted are:
+Securities issued as part of a transaction or transactions
previously announced to the market in an Appendix 3B
Total number of +securities to be quoted
| ASX +security code | Security description | Number of +securities to be quoted | Issue date | |
| ATHO | OPTION EXPIRING 31-AUG-2026 | 285,087,715 | 15/04/2024 |
Refer to next page for full details of the announcement
Part 1 - Entity and announcement details
ALTERITY THERAPEUTICS LIMITED
We (the entity named above) apply for +quotation of the
following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.
| 1.2 Registered number type Registration number | ||
| ACN | 080699065 |
Date of this announcement
Part 2 - Type of Issue
The +securities to be quoted are:
+Securities issued as part of a transaction or transactions
previously announced to the market in an Appendix 3B
Previous Appendix 3B details:
| Announcement Date and Time | Announcement Title | Selected Appendix 3B to submit quotation request | |
| 23-Feb-2024 10:18 | New - Proposed issue of securities - ATH | A placement or other type of issue |
2.3a.2 Are there any further issues of +securities
yet to take place to complete the transaction(s) referred to in the Appendix 3B?
Part 3A - number and type of
+securities to be quoted where issue has previously been notified to ASX in an Appendix 3B
code and description
ATHO : OPTION EXPIRING 31-AUG-2026
Distribution Schedule
Provide a distribution schedule for the new +securities
according to the categories set out in the left hand column - including the number of recipients and the total percentage of the new +securities
held by the recipients in each category.
| Number of +securities held | Number of holders | Total percentage of +securities held For example, to enter a value of 50% please input as 50.00 | |
| 1 - 1,000 | % | ||
| 1,001 - 5,000 | % | ||
| 5,001 - 10,000 | % | ||
| 10,001 - 100,000 | % | ||
| 100,001 and over | % |
Number of +securities to be quoted
Are the +securities being issued for a cash consideration?
Please describe the consideration being provided for
Please provide an estimate (in AUD) of the value of
the consideration being provided per +security for the
+securities to be quoted
Any other information the entity wishes to provide about the +securities to be quoted
Part 4 - Issued capital following quotation
Following the quotation of the +securities the subject
of this application, the issued capital of the entity will comprise:
The figures in parts 4.1 and 4.2 below are automatically
generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently
with ASX for processing.
Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the
+securities subject of this application)
| ASX +security code and description | Total number of +securities on issue | |||
| ATH : ORDINARY FULLY PAID | 5,238,017,899 | |||
| ATHO : OPTION EXPIRING 31-AUG-2026 | 932,706,668 |
Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)
| ASX +security code and description | Total number of +securities on issue | |||
| ATHAAI : OPTION EXPIRING 31-AUG-2024 EX $0.007 | 1,942,857,123 | |||
| ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375 | 19,250,000 | |||
| ATHAAF : OPTION EXPIRING 31-JUL-2024 EX $0.07 | 12,000,000 | |||
| ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238 | 11,900,000 | |||
| ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09 | 35,000,000 | |||
| ATHAAH : OPTION EXPIRING 19-DEC-2026 EX $0.0105 | 8,000,000 | |||
| ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032 | 91,392,720 |